ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

8,831Medicare Part D Prescriptions Filled, Including Refills

Rank: 716 out of 3734

$612K Total Retail Price of All Prescriptions

Rank: 453 out of 3734

401 Patients Receiving at Least One Drug in Part D
81%Patients 65 Years and Older
36% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Pennsylvania
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

10% of this provider’s 401 patients filled at least one prescription for a schedule three drug, compared to an average of 8%.

Risky Drugs to Seniors

1% of this provider’s 7,110 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

25% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$69 was the average price of a prescription from this provider, compared to $57 among peers.

Prescriptions per Patient

22 is the average number of prescriptions (including refills) per patient, compared to an average of 19.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Pennsylvania
SIMVASTATIN 422 341 1 1
LISINOPRIL 331 253 2 3
LEVOTHYROXINE SODIUM 302 261 3 2
METOPROLOL TARTRATE 278 222 4 6
OMEPRAZOLE 271 206 5 4
METFORMIN HCL 229 162 6 8
FUROSEMIDE 203 176 7 7
ATENOLOL 201 188 8 13
AMLODIPINE BESYLATE 162 145 9 5
ATORVASTATIN CALCIUM 157 128 10 11
CITALOPRAM HBR 148 114 11 16
PANTOPRAZOLE SODIUM 138 126 12 22
HYDROCODONE-ACETAMINOPHEN 135 95 S3 13 12
GABAPENTIN 129 98 14 17
LISINOPRIL-HYDROCHLOROTHIAZIDE 123 111 15 27
WARFARIN SODIUM 113 101 16 10
SYNTHROID 112 110 17 47
ISOSORBIDE MONONITRATE ER 107 107 18 34
HYDROCHLOROTHIAZIDE 105 87 19 9
CLOPIDOGREL 96 89 20 23
ALENDRONATE SODIUM 86 60 21 26
PRAVASTATIN SODIUM 80 75 22 15
SPIRIVA 79 62 23 40
ALLOPURINOL 79 66 23 33
SERTRALINE HCL 76 62 25 18
PREDNISONE 76 69 25 42
ADVAIR DISKUS 75 61 27 35
DIOVAN 74 59 28 31
TRAMADOL HCL 73 51 29 20
POTASSIUM CHLORIDE 72 56 30 19
METFORMIN HCL ER 70 64 31 66
CYMBALTA 65 52 32 67
BYSTOLIC 62 62 33 148
GEMFIBROZIL 61 37 34 114
CARVEDILOL 58 54 35 30
ATENOLOL-CHLORTHALIDONE 57 41 36 178
SPIRONOLACTONE 56 44 37 80
CELEBREX 56 50 37 69
FLUTICASONE PROPIONATE 56 47 37 46
DILTIAZEM 24HR ER 54 49 40 86
CRESTOR 53 52 41 28
LOSARTAN POTASSIUM 50 47 42 21
PLAVIX 50 43 42 39
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 15, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.